Clinical Trials Logo

Clinical Trial Summary

Research problem: In 1991, the terms Systemic Inflammatory Response Syndrome (SIRS), severe sepsis, and septic shock were introduced, based on the pro-inflammatory theory, conforming to a list of classification criteria for each one. New criteria were recently created in search of coherence with the pathophysiological process that generates the infection in the host: SOFA and qSOFA scores. Neither of these two criteria has been standardized in the obstetric patient, taking into account the physiological alteration of many of the clinical and laboratory parameters that occur in pregnancy. The question that arises then is: Are the new sepsis criteria qSOFA and SOFA valid in comparison with the previous SIRS criteria for predicting adverse maternal and neonatal outcomes in obstetric patients diagnosed with infection? Aim: To evaluate the predictive model quick Sequential [Sepsis-related] Organ Failure Assessment (qSOFA) in comparison with the SIRS criteria for the prognosis of severe infection-sepsis in obstetric patients and adverse neonatal outcomes in different cities of Colombia. Methodology: a longitudinal prospective cohort multicenter study will be carried out in selected centers in Colombia, with a data collection duration of at least 12 months. Data will be collected on clinical characteristics, health outcomes, and medical practices. Study participants will be followed during their stay at the health center. Follow-up will end at hospital discharge, transfer to a facility outside of participating geographic areas, or death. Neonates born to mothers included in the study will be followed until discharge from the hospital or 7 days after birth if they are still in the hospital, whichever comes first. Expected results: This study seeks to evaluate the predictive model q SOFA and the prognosis of sepsis in obstetrics in comparison with the SIRS criteria, hoping to find that qSOFA is superior to the SIRS criteria for the identification of which obstetric patients diagnosed with an infection they will progress to sepsis and which patients with sepsis progress to septic shock, this would translate both at the maternal and neonatal level in a reduction of adverse events, prolonged stays, disabilities, sequelae, in addition to allowing preventive actions and control, which finally translate into protocols that allow better management of this entity.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04621539
Study type Observational
Source Fundación Grupo de Investigación en Cuidados Intensivos y Obstetricia
Contact
Status Completed
Phase
Start date January 1, 2018
Completion date November 13, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT04990908 - Systematic Screening for Primary Immunodeficiencies in Patients Admitted for Severe Infection in Pediatric Intensive Care Unit
Recruiting NCT05788861 - Invasive Group A Streptococcal Infection
Recruiting NCT05602324 - Nutritional Supplement for Patients With Severe Infection N/A
Active, not recruiting NCT02846298 - Evaluation of Pharmacokinetic / Pharmacodynamic Data and Interest Individualized Therapeutic Drug Monitoring Glycopeptides and β-lactam-aminoglycoside ICU
Recruiting NCT04650607 - Phage Safety Cohort Study
Recruiting NCT02167802 - Construction and Validation of a Tool for Automatic Identification of Care Pathways at Risk of Sub-optimality in the Management of Severe Infections in Children (DIABACT IV)
Completed NCT03145428 - Evaluation of Monocyte Volume Distribution Width (MDW) for Early Detection of Sepsis
Terminated NCT05210387 - Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections N/A
Recruiting NCT06260345 - CommunautAry Pediatric bacteRial Infection in Intensive CarE Unit
Recruiting NCT06161870 - Clinical Study of Individualized Vancomycin Dosing Based on Population PK Model Phase 4
Recruiting NCT06185920 - PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL.
Recruiting NCT04923828 - Chinese PICU Collaborative Network on Pathogens and Drug Resistance of Severe Infections
Completed NCT03588325 - Evaluation of MDW for Early Detection of Sepsis, Clinical Validity